BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12091634)

  • 1. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.6. Cardiovascular risks. Smoking.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():29. PubMed ID: 12091634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.7. Cardiovascular risks. Obesity and weight gain.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():29-30. PubMed ID: 12091635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.5. Cardiovascular risks. Hyperhomocysteinaemia.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():28-9. PubMed ID: 12091633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.3 Chronic graft dysfunction. Non-alloimmune factors.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():11-5. PubMed ID: 12091619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.2 Chronic graft dysfunction. Immunological factors (alloimmunity).
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():8-11. PubMed ID: 12091618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.1. Cardiovascular risks. Cardiovascular disease after renal transplantation.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():24-5. PubMed ID: 12091628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.3. Haematological complications. Erythrocytosis.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():49-50. PubMed ID: 12091649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.2. Long-term immunosuppression. Therapy conversion.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():20-1. PubMed ID: 12091625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.2. Cardiovascular risks. Arterial hypertension.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():25-6. PubMed ID: 12091630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.4. Cardiovascular risks. Post-transplant diabetes mellitus.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():28. PubMed ID: 12091632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.3. Long-term immunosuppression. Toxicity of immunosuppression.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():21-3. PubMed ID: 12091626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():1-67. PubMed ID: 12484407
    [No Abstract]   [Full Text] [Related]  

  • 13. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.3. Cardiovascular risks. Hyperlipidaemia.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():26-8. PubMed ID: 12091631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular disease after renal transplantation].
    Montanaro D; Gropuzzo M; Tulissi P; Boscutti G; Risaliti A; Baccarani U; Adani GL; Sainz M; Bresadola F; Mioni G
    G Ital Nefrol; 2004; 21 Suppl 26():S53-66. PubMed ID: 15732047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoking and chronic allograft nephropathy.
    Zitt N; Kollerits B; Neyer U; Mark W; Heininger D; Mayer G; Kronenberg F; Lhotta K
    Nephrol Dial Transplant; 2007 Oct; 22(10):3034-9. PubMed ID: 17517794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
    Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
    J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.2.6. Chronic graft dysfunction. Late recurrence of other diseases.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():18-9. PubMed ID: 12091622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.1. Organization of follow-up of transplant patients after the first year.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():3-4. PubMed ID: 12091614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.4. Long-term immunosuppression. Non-compliance.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():23-4. PubMed ID: 12091627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():32, 34-6. PubMed ID: 12091641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.